glp 1 growth hormone Glucagon-like peptide (GLP)-1 and GLP-2 are multi-organ hormones that Study: Popular GLP-1 Drug May

A study of adults with diabetes suggests patients with obstructive sleep apnea derive a 20% greater mortality reduction from GLP-1 therapy than those without the sleep disorder.

GLP-1 on hormoni, joka osallistuu ruokahalun stelyyn ja verensokeritasapainon yllpitmiseen

Why Injection Site Matters for GLP-1 Medications We have spent a lot of time exploring glucagon-like peptide-1 receptor agonists (GLP-1 agonists)

Serena Williams used GLP-1 medication to lose 31 pounds after facing postpartum weight challenges, saying she now feels healthier and more energetic

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course